PUBLICATION

Let's get small (and smaller): Combining zebrafish and nanomedicine to advance neuroregenerative therapeutics

Authors
White, D.T., Saxena, M.T., Mumm, J.S.
ID
ZDB-PUB-190216-11
Date
2019
Source
Advanced drug delivery reviews   148: 344-359 (Review)
Registered Authors
Mumm, Jeff, Saxena, Meera T., White, David T.
Keywords
Drug optimization, Nanocarrier, Neurodegeneration, Neuroregeneration
MeSH Terms
  • Animals
  • Drug Delivery Systems
  • Drug Discovery
  • Humans
  • Nanomedicine*
  • Nanoparticles/chemistry*
  • Neurodegenerative Diseases/drug therapy*
  • Neuroprotective Agents/chemistry
  • Neuroprotective Agents/therapeutic use*
  • Regenerative Medicine
  • Zebrafish
PubMed
30769046 Full text @ Adv. Drug Deliv. Rev.
Abstract
Several key attributes of zebrafish make them an ideal model system for the discovery and development of regeneration promoting therapeutics; most notably their robust capacity for self-repair which extends to the central nervous system. Further, by enabling large-scale drug discovery directly in living vertebrate disease models, zebrafish circumvent critical bottlenecks which have driven drug development costs up. This review summarizes currently available zebrafish phenotypic screening platforms, HTS-ready neurodegenerative disease modeling strategies, zebrafish small molecule screens which have succeeded in identifying regeneration promoting compounds and explores how intravital imaging in zebrafish can facilitate comprehensive analysis of nanocarrier biodistribution and pharmacokinetics. Finally, we discuss the benefits and challenges attending the combination of zebrafish and nanoparticle-based drug optimization, highlighting inspiring proof-of-concept studies and looking toward implementation across the drug development community.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping